The Michael J. Neustadter Pancreatic Cancer Fund was created in memory of Michael Neustadter in recognition of his courageous battle and determination to beat this dreadful disease. Its mission is to support the fight against pancreatic cancer and contribute to the discovery of a cure.
Michael Neustadter lost his battle on January 19th, 2012, only a year after learning he had pancreatic cancer. Despite an early diagnosis, a healthy lifestyle and some of the best medical care in the nation, the disease proved too relentless to withstand. Michael spent his life helping others and giving back to the community, from his work with numerous charities to serving as chairman of the board of the Atlanticare Health System. He would be proud to know that his name lives on as a catalyst for curing this life-threatening disease.
With generous support from the Michael J. Neustadter Pancreatic Cancer fund, the Penn Pancreatic Cancer Research Center, in collaboration with the Basser Center, is developing a point-of-care testing program for pancreatic cancer patients, with a goal of identifying patients with genetic risk for pancreatic cancer. With this information, the team can develop improved personalized treatment plans for those patients, and learn more about the genetics of pancreatic cancer.